Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Diasoft maintains plans to hold an SPO

12/10/24 DIAS

Fesco launched a direct container line Vladivostok-Shanghai

12/9/24 FESH

Shareholders of Severstal approved dividends

12/9/24 CHMF

Moscow Exchange launches IPO calendar

12/9/24 MOEX

VK may bring VK Tech to IPO

12/9/24 VKCO

Henderson's revenue for 11 months of 2024 grew 23.7%

12/9/24 HNFG

Shareholders of IMCB approved dividends

12/9/24 GEMA

M.Video-Eldorado entered the secondary market

12/9/24 MVID

Headhunter shareholders approved special dividends

12/9/24 HEAD

Alardinskaya mine suspended operations due to fire

12/9/24 RASP